Rezultati

eNauka >  Rezultati >  Patient-reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2–positive breast cancer
Naziv: Patient-reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2–positive breast cancer
Autori: Conte PierFranco; Schneeweiss Andreas; Loibl Sibylle; Mamounas Eleftherios; von Minckwitz Gunter; Mano Max S; Untch Michael; Huang Chiun-Sheng; Wolmark Norman; Rastogi Priya;
D'Hondt Veronique; Redondo Andres; Stamatović Ljiljana; Bonnefoi Hervé; Castro-Salguero Hugo; Fischer Hans H; Wahl Tanya; Song Chunyan; Boulet Thomas; Trask Peter; Geyer Charles E Jr.;
Godina: 2020
Publikacija: Cancer 126(13) 3132-3139
ISSN: 0008-543X Cancer Pretraži identifikator
Tip rezultata: Naučni članak
Kolacija: vol. 126 br. 13 str. 3132-3139
DOI: 10.1002/cncr.32873
WoS-ID: 000525904300001
Scopus-ID: 2-s2.0-85083380575
PMID: 32286687
PMCID: PMC7317721
URI: https://zenodo.org/record/4773213
https://enauka.gov.rs/handle/123456789/597578
Projekat: pmcid:PMC7317721
gnd:gnd:1097-0142.
M-kategorija: 
21aM21a - Vodeći međunarodni časopis kategorije M21a

25
SCOPUSTM
13
PubMed CentralTM
8
OpenCitations
21
WEB OF SCIENCETM
Alt metrika
Dimensions
Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.